ulbi20190918_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 
 

FORM 8-K

 
 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 
 

September 18, 2019

Date of Report (Date of Earliest Event Reported)

 
 

ULTRALIFE CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

000-20852

16-1387013

(State of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

2000 Technology Parkway, Newark, New York 14513

(Address of principal executive offices) (Zip Code)

 

(315) 332-7100

(Registrant’s telephone number, including area code)

 

None

(Former name or former address, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Common Stock, $0.10 par value per share

ULBI

NASDAQ

(Title of each class)

(Trading Symbol)

(Name of each exchange on which registered)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

  

 

 

 

Item 8.01    Other Events

 

In a press release dated September 19, 2019, Ultralife Corporation (NASDAQ: ULBI) announced that it has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract for purchases not to exceed $14.4 million from the U.S. Government’s Defense Logistics Agency (DLA) for its lithium manganese dioxide, non-rechargeable BA-5368 batteries. These batteries are used in a variety of military applications, including detectors and imaging. The award consists of a three-year base contract with two one-year option periods. The amounts and timing of deliveries under this contract are at the discretion of the DLA.

 

 

Item 9.01     Financial Statements, Pro Forma Financials and Exhibits

 

(d) Exhibits

 

Exhibit

Number

  Description
     
 99.1

 

Press Release of Ultralife Corporation dated September 19, 2019

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 19, 2019

 

ULTRALIFE Corporation

     
     
 

By:

/s/ Philip A. Fain

   

Philip A. Fain

   

Chief Financial Officer and Treasurer

 

ex_158165.htm

Exhibit 99.1

 

 

Ultralife Corporation Receives $14.4 Million IDIQ Award

from Defense Logistics Agency for BA-5368 Military Batteries

 

 

NEWARK, N.Y. September 19, 2019 -- Ultralife Corporation (NASDAQ: ULBI) has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract for purchases not to exceed $14.4 million from the U.S. Government’s Defense Logistics Agency (DLA) for its lithium manganese dioxide, non-rechargeable BA-5368 batteries. These batteries are used in a variety of military applications, including detectors and imaging. The award consists of a three-year base contract with two one-year option periods.  The amounts and timing of deliveries under this contract are at the discretion of the DLA.

 

“Ultralife is a long-standing supplier to the U.S. military, and our BA-5368 battery is recognized for its long life, high energy density, and proven safety, performance and reliability across a wide temperature range.  We are pleased that DLA has selected Ultralife once again,” said Michael D. Popielec, President and Chief Executive Officer.

 

About Ultralife Corporation

 

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

 

Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.

 

Company Contact:

Ultralife Corporation

Philip A. Fain

(315) 210-6110

pfain@ulbi.com

 

Investor Relations Contact:

 

LHA

 

Jody Burfening

 

(212) 838-3777

 

jburfening@lhai.com